sameAs
P3781
Elevated phenylacetic acid levels do not correlate with adverse events in patients with urea cycle disorders or hepatic encephalopathy and can be predicted based on the plasma PAA to PAGN ratio.Observational Study That Will Collect Information on Patients With Urea Cycle Disorders (UCDs)A Study of the Safety, Efficacy and Pharmacokinetics of Glycerol Phenylbutyrate in Pediatric Subjects Under 2 Years of Age With Urea Cycle DisordersA Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic EncephalopathyGlycerol Phenylbutyrate Corrector Therapy For CF (Cystic Fibrosis)Use of Ravicti™ in Patients With MCAD Deficiency With the 985A>G (K304E) Mutation
P921
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Glicerol fenilbutirat
@sh
Glicerol fenilbutirat
@sr
glycerol phenylbutyrate
@en
גליצרול פנילבוטיראט
@he
type
label
Glicerol fenilbutirat
@sh
Glicerol fenilbutirat
@sr
glycerol phenylbutyrate
@en
גליצרול פנילבוטיראט
@he
altLabel
GPB
@en
GT4P
@en
Glycerol Phenylbutyrate
@en
Glycerol phenylbutyrate
@en
Glyceryl Tri-4-Phenylbutyrate
@en
HPN-100
@en
HPN100
@en
prefLabel
Glicerol fenilbutirat
@sh
Glicerol fenilbutirat
@sr
glycerol phenylbutyrate
@en
גליצרול פנילבוטיראט
@he
P592
P6366
P661
P662
P665
P6694
P683
P2067
530.266839
P2115
N0000186573
P2275
Glycerol Phenylbutyrate
@en
P231
611168-24-2
P232
P233
C1=CC=C(C=C1)CCCC(=O)OCC(COC(=O)CCCC2=CC=CC=C2)OC(=O)CCCC3=CC=CC=C3
P234
1S/C33H38O6/c34-31(22-10-19-27 ...... 8/h1-9,13-18,30H,10-12,19-26H2
P235
ZSDBFLMJVAGKOU-UHFFFAOYSA-N
P2566
100.228.552